DBV Technologies | Ativo Circulante



Current Assets Alterar Data
Acadia Pharmaceuticals USD 938.32M 150.03M 2024-12
Alnylam Pharmaceuticals USD 3.3B 60.14M 2024-12
Amarin USD 650.22M 51.62M 2024-09
BioMarin Pharmaceutical USD 3.23B 175.84M 2024-12
DBV Technologies USD 68.76M 21.2M 2024-09
Halozyme Therapeutics USD 1.09B 41.64M 2024-12
Incyte USD 3.24B 430.32M 2024-12
Insmed USD 1.62B 28.18M 2024-12
Ionis Pharmaceuticals USD 2.62B 93.56M 2024-12
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
PTC Therapeutics USD 1.37B 83.98M 2024-12
Sarepta Therapeutics USD 3.07B 388.09M 2024-12
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
United Therapeutics USD 3.87B 126.5M 2024-12



DBV Technologies Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.